Article
Shareholder Value Reporting in Europe - Solvency II Based Metrics
We consider the impact of the pandemic to firms’ supplementary reporting metrics, and their level of Solvency II Own Funds and solvency positions.
Is the vaccine for COVID-19 a white knight for employers?
By Les Kartchner and Brent Jensen
28 December 2020
What are some considerations for employers as new COVID-19 vaccines are made available? Employers will need to address several issues in order to facilitate safe and efficient returns to standard business practices.
Explore more tags from this article
INSIGHT